1.
Exp Clin Transplant
; 18(1): 110-111, 2020 02.
Article
in English
| MEDLINE
| ID: mdl-29969081
ABSTRACT
Early trials of tacrolimus in renal transplant recipients have not revealed hearing loss as an adverse effect. Here, we present a case report and a review of the literature of deafness after tacrolimus use. The review of the literature and our experience suggested that the possible reason for hearing loss could be due to an initiation of a sudden spike in the tacrolimus serum level, which was later worsened by its cumulative toxic effect.